Clinical Trials Directory

Trials / Completed

CompletedNCT03688490

Clinical Characteristics of Aquagenic Pruritus in Patients With Myeloproliferative Neoplasms

Aquagenic Pruritus Among Patients With Myeloproliferative Syndromes (in English) Prurit Aquagénique Dans Les SYndromes MyéloProLifEratifs (in French)

Status
Completed
Phase
Study type
Observational
Enrollment
70 (actual)
Sponsor
University Hospital, Brest · Academic / Other
Sex
All
Age
Healthy volunteers
Not accepted

Summary

Description of the characteristics of aquagenic pruritus expressed by patients suffering from myeloproliferative neoplasms. Prospective work based on the distribution of a dedicated questionnaire.

Detailed description

Patients with myeloproliferative neoplasms identified and followed in our Institution (Brest University Hospital). Patients could be followed for polycythemia vera or essential thrombocythemia or myelofibrosis. Distribution of the questionnaire to each patients with myeloproliferative neoplasms (treated or not) suffering from aquagenic pruritus. Analyse of each characteristic of the aquagenic pruritus by a statistician and publication at the end.

Conditions

Timeline

Start date
2013-07-17
Primary completion
2013-11-04
Completion
2013-11-04
First posted
2018-09-28
Last updated
2019-07-01

Source: ClinicalTrials.gov record NCT03688490. Inclusion in this directory is not an endorsement.